Cancer Drugs Recent News
Analyst: Is The Street Ignoring Pfizer And Its Upcoming Catalysts?
Gilead Gets An Upgrade Amid 'Game-Changing' Kite Deal
ZIOPHARM Announces Clinical Data On Brain Cancer Drug
Exclusive: Oasmia Chairman Talks About How They're Changing Cancer Drug Delivery Treatment
Bristol-Myers Hit With A Trio Of Analyst Price Target Cuts
Medivation Drops 12% After Congress Asks To Examine Xtandi Drug Price
Incyte To Stop A Phase 2 Sub-Study, Shares Lose 10%
OncoMed Pharma Crashes 40% After Poor Trial Data
Here's Why Shares Of Onco Genex Pharma Are Plunging
Juno Therapeutics Lower, To Acquire AbVitro For $78 Million In Cash And Nearly 1.30 Million Shares
Vetr Crowd No Longer Uber-Bearish On Puma Biotech
Market Wrap For January 27: China Concerns, Declining Home Sales, Tomorrow's Fed Meeting and Obama's Speech Keep Markets Lower